{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(11)"],"submitter":["Hoang LT"],"pubmed_abstract":["Lung cancer is the leading cause of cancer-related deaths in the world. The most prevalent subtype, accounting for 85% of cases, is non-small-cell lung cancer (NSCLC). Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) are the most common subtypes. Despite recent advances in treatment, the low 5-year survival rate of NSCLC patients (approximately 13%) reflects the lack of early diagnostic biomarkers and incomplete understanding of the underlying disease mechanisms. We hypothesized that integration of metabolomic, transcriptomic and genetic profiles of tumours and matched normal tissues could help to identify important factors and potential therapeutic targets that contribute to tumorigenesis. We integrated omics profiles in tumours and matched adjacent normal tissues of pat"],"journal":["Molecular oncology"],"pagination":["2406-2421"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6822241"],"repository":["biostudies-literature"],"pubmed_title":["Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer."],"pmcid":["PMC6822241"],"pubmed_authors":["Nicholson AG","Starren ES","Morris-Rosendahl DJ","Willis-Owen SAG","Domingo-Sabugo C","Cookson WOCM","Hoang LT","Moffatt MF"],"additional_accession":[]},"is_claimable":false,"name":"Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer.","description":"Lung cancer is the leading cause of cancer-related deaths in the world. The most prevalent subtype, accounting for 85% of cases, is non-small-cell lung cancer (NSCLC). Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) are the most common subtypes. Despite recent advances in treatment, the low 5-year survival rate of NSCLC patients (approximately 13%) reflects the lack of early diagnostic biomarkers and incomplete understanding of the underlying disease mechanisms. We hypothesized that integration of metabolomic, transcriptomic and genetic profiles of tumours and matched normal tissues could help to identify important factors and potential therapeutic targets that contribute to tumorigenesis. We integrated omics profiles in tumours and matched adjacent normal tissues of pat","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Nov","modification":"2026-05-03T19:14:27.099Z","creation":"2019-11-13T08:02:53Z"},"accession":"S-EPMC6822241","cross_references":{"pubmed":["31461552"],"doi":["10.1002/1878-0261.12568"]}}